Table 1.
Age of mice (weeks) | # of total mice monitored | Tumor frequency of all mice (%) | # of female mice monitored | Tumor frequency of female mice (%) | # of male mice monitored | Tumor frequency of male mice (%) |
---|---|---|---|---|---|---|
3 | 12 | 0 | 6 | 0 | 6 | 0 |
5 | 18 | 0 | 10 | 0 | 8 | 0 |
7 | 23 | 8.7 | 13 | 7.7 | 10 | 10 |
9 | 23 | 43.5 | 14 | 50 | 9 | 33.3 |
11 | 22 | 68.2 | 16 | 68.8 | 6 | 66.7 |
13 | 27 | 85.2 | 15 | 80 | 12 | 91.7 |
15 | 23 | 95.7 | 6 | 100 | 17 | 94.1 |
17 | 17 | 100 | 17 | 100 | ||
19 | 2 | 100 | 1 | 100 | 1 | 100 |
23 | 2 | 100 | 2 | 100 |
PanNET pancreatic neuroendocrine tumor, MPR Men1flox/flox Ptenflox/flox RIP-Cre